Clean Yield Group Gilead Sciences, Inc. Transaction History

Clean Yield Group

$293 Million
Q4 2024

A detailed history of Clean Yield Group transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Clean Yield Group holds 160 shares of GILD stock, worth $18,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

160

Previous 160 -0.0%

Holding current value

$18,308

Previous $13,000 7.69%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	BUY	$66.59 - $83.99 $10,654 - $13,438	160 New	160 $13,000
Q3 2023 Oct 12, 2023	BUY	$73.94 - $80.67 $7,320 - $7,986	99 New	99 $7,000
Q4 2022 Jan 31, 2023	SELL	$62.32 - $89.47 $1,869 - $2,684	-30 Reduced 60.0%	20 $1,000
Q3 2022 Oct 31, 2022	SELL	$59.54 - $68.01 $29,770 - $34,005	-500 Reduced 90.91%	50 $3,000
Q2 2022 Jul 18, 2022	SELL	$57.72 - $65.01 $6,926 - $7,801	-120 Reduced 17.91%	550 $34,000
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $868 - $1,088	-15 Reduced 2.19%	670 $40,000
Q4 2021 Jan 24, 2022	SELL	$64.88 - $73.64 $86,290 - $97,941	-1,330 Reduced 66.0%	685 $50,000
Q3 2021 Oct 27, 2021	SELL	$67.69 - $73.03 $19,630 - $21,178	-290 Reduced 12.58%	2,015 $141,000
Q2 2021 Jul 26, 2021	SELL	$63.47 - $69.35 $134,873 - $147,368	-2,125 Reduced 47.97%	2,305 $159,000
Q1 2021 Apr 26, 2021	SELL	$60.0 - $68.46 $161,580 - $184,362	-2,693 Reduced 37.81%	4,430 $286,000
Q4 2020 Jan 26, 2021	SELL	$56.65 - $64.55 $1.25 Million - $1.42 Million	-22,017 Reduced 75.56%	7,123 $415,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $784,819 - $986,775	-12,638 Reduced 30.25%	29,140 $1.84 Million
Q2 2020 Jul 22, 2020	SELL	$72.34 - $84.0 $45,863 - $53,256	-634 Reduced 1.49%	41,778 $3.21 Million
Q1 2020 Apr 20, 2020	SELL	$62.63 - $80.22 $121,439 - $155,546	-1,939 Reduced 4.37%	42,412 $3.17 Million
Q4 2019 Jan 17, 2020	SELL	$61.62 - $67.78 $655,636 - $721,179	-10,640 Reduced 19.35%	44,351 $2.88 Million
Q3 2019 Oct 23, 2019	BUY	$62.51 - $69.0 $25,316 - $27,945	405 Added 0.74%	54,991 $3.49 Million
Q2 2019 Jul 22, 2019	BUY	$61.87 - $69.38 $4,021 - $4,509	65 Added 0.12%	54,586 $3.69 Million
Q1 2019 Apr 24, 2019	BUY	$62.53 - $70.05 $786,689 - $881,299	12,581 Added 30.0%	54,521 $3.54 Million
Q4 2018 Jan 23, 2019	SELL	$60.54 - $79.0 $185,736 - $242,372	-3,068 Reduced 6.82%	41,940 $2.62 Million
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $13,400 - $14,836	-188 Reduced 0.42%	45,008 $3.48 Million
Q2 2018 Jul 24, 2018	BUY	$64.88 - $75.68 $32,699 - $38,142	504 Added 1.13%	45,196 $3.2 Million
Q1 2018 Apr 23, 2018	SELL	$72.84 - $88.8 $7,284 - $8,880	-100 Reduced 0.22%	44,692 $3.37 Million
Q4 2017 Jan 16, 2018	SELL	$71.15 - $83.52 $211,315 - $248,054	-2,970 Reduced 6.22%	44,792 $3.21 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $3.44 Million - $4.08 Million	47,762	47,762 $3.87 Million

Others Institutions Holding GILD

# of Institutions

2,100

Shares Held

1.02B

Call Options Held

8.73M

Put Options Held

9.63M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $143B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Account

Clean Yield Group Gilead Sciences, Inc. Transaction History